题名

小陷胸湯合抵當湯治療COVID-19驗案二則

并列篇名

Treating COVID-19 with Xiao Xianxiong Decoction and Didang Decoction: Two Case Reports

DOI

10.6516/TJTCM.202203/SP_25.0009

作者

莊志瑜(Chih-Yu Chuang)；張（王夋）瑛(Chun-Ying Chang)；鄭宏足(Hung-Tsu Cheng)

关键词

小陷胸湯 ； 抵當湯 ； 傷寒雜病論 ； 中醫 ； COVID-19 ； Xiao Xianxiong Decoction ； Didang Decoction ； Shang Han Za Bing Lun ； Traditional Chinese Medicine ； COVID-19

期刊名称

中醫藥研究論叢

卷期/出版年月

25卷特刊（2022 / 03 / 05）

页次

65 - 69

内容语文

繁體中文
中文摘要

茲介紹COVID-19確診者「中度肺炎」階段驗案二則。症見咳嗽，或有黃綠濃痰夾血絲，或有微喘、發熱；經中醫視訊看診，辨為太陽病誤下之結胸證，又恐瘀血阻絡，故與小陷胸湯合抵當湯治之。療效明確，諸症皆癒。
英文摘要

These are two cases of COVID-19 confirmed patients in the moderate pneumonia stage. The symptoms are cough, yellow-green thick sputum with a little bloodshot, or slight wheezing and fever. Through video consultation, they were diagnosed by TCM as the Blocked-up Chest (Jiexiong) syndrome caused by mistreatment of giving a purgative to dispel the Initial Yang (Taiyang) syndrome. And, to avoid blood stasis and block the meridians, we combined Xiao Xianxiong Decoction and Didang Decoction for treatment. The curative effect is clear, and all symptoms are cured.
主题分类 醫藥衛生 > 中醫藥學
醫藥衛生 > 藥理醫學
参考文献
  1. 衛生福利部疾病管制署。2022 年 1 月 24 日，取自 https://www.cdc.gov.tw/
  2. Tsai, Keng-Chang,Huang, Yi-Chia(2021).A Traditional Chinese Medicine Formula NRICM101 to Target COVID-19 through Multiple Pathways: A Bedside-to-Bench Study.Biomedicine & Phar macotherapy,133,111037.
  3. 衛生福利部疾病管制署。新型冠狀病毒（SARS-CoV-2）感染臨床處置暫行指引第十五版。2022 年 01 月 24 日，取自 www.cdc.gov.tw/Category/Page/xCSwc5oznwcqunujPc-qmQ
  4. 鄭宏足,莊志瑜(2018).傷寒金匱方藥速查.台北:知音出版社.
print cancel